Energy Recovery revenue drops 65% in Q3 2026
Management believes existing resources and projected cash inflows will meet liquidity needs for at least 12 months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Energy Recovery, Inc. reported third-quarter 2026 revenue of $11.2 million, down 65% from $32.0 million a year earlier, and a net loss of $6.3 million, versus net income of $3.9 million. Gross margin was 37.5%, compared with 64.2%. Megaproject revenue was $934,000, down from $18.4 million, primarily reflecting lower shipments to Africa, Asia and the Middle East.
For the nine months ended September 30, revenue was $32.9 million versus $68.1 million, and net loss was $21.8 million versus $4.0 million. Operating cash flow was $28.1 million, compared with $11.7 million. The company wound down its CO2 retail grocery business, recording $2.4 million of restructuring charges, $1.6 million of inventory reserves and $1.7 million of goodwill impairment.
At September 30, 2026, cash and equivalents were $42.5 million and short- and long-term investments were $43.1 million. Management believes current projections indicate these resources and future portfolio cash inflows will meet liquidity needs for at least 12 months.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month operating cash flow rose to $28.1 million from $11.7 million.
Negative
- Moderate pointThird-quarter revenue declined 65% to $11.2 million year over year.
- Moderate pointThird-quarter net results shifted from $3.9 million income to a $6.3 million loss.
Filing Explained
Nine-month buybacks lowered the share count, while the May authorization remained optional, not promised spending.
The report identifies a
During the nine months ended
Key Figures
Key Terms
Remaining Performance Obligations financial
treasury stock method financial
contract liabilities financial
weighted average maturity financial
anti-dilutive financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did ERII's megaproject revenue fall in Q3 2026?
How much cash and investment liquidity did ERII report?
How much remains under ERII's May 2026 share repurchase authorization?
AI-generated analysis. How Rhea-AI works. Not financial advice.

(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Page No. | ||
PART I | ||
FINANCIAL INFORMATION | ||
Item 1 | Financial Statements (Unaudited) | |
Condensed Consolidated Balance Sheets — September 30, 2026 and December 31, 2025 | 1 | |
Condensed Consolidated Statements of Operations — Three and Nine Months Ended September 30, 2026 and 2025 | 2 | |
Condensed Consolidated Statements of Comprehensive Income (Loss) — Three and Nine Months Ended September 30, 2026 and 2025 | 3 | |
Condensed Consolidated Statements of Stockholders’ Equity — Three and Nine Months Ended September 30, 2026 and 2025 | 4 | |
Condensed Consolidated Statements of Cash Flows — Nine Months Ended September 30, 2026 and 2025 | 5 | |
Notes to Condensed Consolidated Financial Statements | 6 | |
Item 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21 |
Item 3 | Quantitative and Qualitative Disclosures About Market Risk | 30 |
Item 4 | Controls and Procedures | 31 |
PART II | ||
OTHER INFORMATION | ||
Item 1 | Legal Proceedings | 32 |
Item 1A | Risk Factors | 32 |
Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 34 |
Item 3 | Defaults Upon Senior Securities | 34 |
Item 4 | Mine Safety Disclosures | 34 |
Item 5 | Other Information | 34 |
Item 6 | Exhibits | 36 |
Exhibit Index | 36 | |
Signatures | 37 | |
•our belief that our PX offers market-leading value with the highest technological and economic benefit; |
•our belief that leveraging our pressure exchanger technology will unlock new commercial opportunities in the future; |
•our belief that our technology helps our customers achieve environmentally sustainable operations; |
•our expectation that sales outside of the U.S. will remain a significant portion of our revenue; |
•the scale of the environmental impact from the use of our solutions; |
•the timing of our receipt of payment for products or services from our customers; |
•our belief that our existing cash and cash equivalents, our short and/or long-term investments, and the ongoing cash generated from our operations, will be sufficient to meet our anticipated liquidity needs for the foreseeable future, with the exception of a decision to enter into an acquisition and/or fund investments in our latest technology arising from rapid market adoption that could require us to seek additional equity or debt financing; |
•our expectations relating to the amount and timing of recognized revenue from our projects; |
•our expectation that we will continue to receive a tax benefit related to research and development tax credit; |
•the outcome of proceedings, lawsuits, disputes and claims; |
•the impact of losses due to indemnification obligations; |
•other factors disclosed under the MD&A and Part I, Item 3, “Quantitative and Qualitative Disclosures about Market Risk,” and elsewhere in this Form 10-Q. |
September 30, 2026 | December 31, 2025 | ||
(In thousands) | |||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Short-term investments | |||
Accounts receivable, net | |||
Inventories, net | |||
Prepaid expenses and other assets | |||
Total current assets | |||
Long-term investments | |||
Deferred tax assets, net | |||
Property and equipment, net | |||
Operating lease, right of use asset | |||
Goodwill | |||
Other assets, non-current | |||
Total assets | $ | $ | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses and other liabilities | |||
Lease liabilities | |||
Contract liabilities | |||
Total current liabilities | |||
Lease liabilities, non-current | |||
Other liabilities, non-current | |||
Total liabilities | |||
Commitments and contingencies (Note 7) | |||
Stockholders’ equity: | |||
Common stock | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Treasury stock | ( | ( | |
Retained earnings | |||
Total stockholders’ equity | |||
Total liabilities and stockholders’ equity | $ | $ | |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
(In thousands, except per share data) | |||||||
Revenue | $ | $ | $ | $ | |||
Cost of revenue | |||||||
Restructuring - inventory reserve | |||||||
Gross profit | |||||||
Operating expenses: | |||||||
General and administrative | |||||||
Sales and marketing | |||||||
Research and development | |||||||
Restructuring charges | |||||||
Impairment of goodwill | |||||||
Total operating expenses | |||||||
Income (loss) from operations | ( | ( | ( | ||||
Other income (expense): | |||||||
Interest income | |||||||
Other non-operating income (expense), net | ( | ||||||
Total other income, net | |||||||
Income (loss) before income taxes | ( | ( | ( | ||||
Provision for (benefit from) income taxes | ( | ( | ( | ||||
Net income (loss) | $( | $ | $( | $( | |||
Net income (loss) per share: | |||||||
Basic | $ ( | $ | $ ( | $ ( | |||
Diluted | $ ( | $ | $ ( | $ ( | |||
Number of shares used in per share calculations: | |||||||
Basic | |||||||
Diluted | |||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
(In thousands) | ||||||||
Net income (loss) | $( | $ | $( | $( | ||||
Other comprehensive loss, net of tax | ||||||||
Foreign currency translation adjustments | ( | ( | ( | ( | ||||
Unrealized gain (loss) on investments | ( | ( | ( | |||||
Total other comprehensive loss, net of tax | ( | ( | ( | ( | ||||
Comprehensive income (loss) | $( | $ | $( | $( | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
(In thousands, except shares) | ||||||||
Common stock | ||||||||
Beginning balance | $ | $ | $ | $ | ||||
Issuance of common stock | ||||||||
Ending balance | ||||||||
Additional paid-in capital | ||||||||
Beginning balance | ||||||||
Issuance of common stock | ||||||||
Shares held for tax withholdings | ( | ( | ( | ( | ||||
Stock-based compensation | ||||||||
Ending balance | ||||||||
Accumulated other comprehensive (loss) income | ||||||||
Beginning balance | ( | ( | ||||||
Other comprehensive loss | ||||||||
Foreign currency translation adjustments | ( | ( | ( | ( | ||||
Unrealized (loss) gain on investments | ( | ( | ( | |||||
Total other comprehensive loss, net | ( | ( | ( | ( | ||||
Ending balance | ( | ( | ||||||
Treasury stock | ||||||||
Beginning balance | ( | ( | ( | ( | ||||
Common stock repurchased | ( | ( | ( | ( | ||||
Ending balance | ( | ( | ( | ( | ||||
Retained earnings | ||||||||
Beginning balance | ||||||||
Net (loss) income | ( | ( | ( | |||||
Ending balance | ||||||||
Total stockholders’ equity | $ | $ | $ | $ | ||||
Common stock issued (shares) | ||||||||
Beginning balance | ||||||||
Issuance of common stock | ||||||||
Ending balance | ||||||||
Treasury stock (shares) | ||||||||
Beginning balance | ||||||||
Common stock repurchased | ||||||||
Ending balance | ||||||||
Total common stock outstanding (shares) | ||||||||
Beginning Balance | ||||||||
Issuance of common stock | ||||||||
Common stock repurchased | ( | ( | ( | ( | ||||
Ending Balance | ||||||||
Nine Months Ended September 30, | |||
2026 | 2025 | ||
(In thousands) | |||
Cash flows from operating activities: | |||
Net loss | $( | $( | |
Adjustments to reconcile net loss to cash provided by (used in) operating activities | |||
Stock-based compensation | |||
Depreciation and amortization | |||
Accretion (amortization) of discounts (premiums) on investments | ( | ( | |
Deferred income taxes | ( | ( | |
Impairment of long-lived assets | |||
Impairment of goodwill | |||
Restructuring - inventory reserve | |||
Inventory reserve adjustment | |||
Other non-cash adjustments | ( | ( | |
Changes in operating assets and liabilities: | |||
Accounts receivable, net | |||
Contract assets | ( | ||
Inventories, net | ( | ( | |
Prepaid expenses and other assets | ( | ( | |
Accounts payable | |||
Income taxes | ( | ( | |
Accrued expenses and other liabilities | ( | ( | |
Contract liabilities | ( | ||
Net cash provided by operating activities | |||
Cash flows from investing activities: | |||
Maturities of marketable securities | |||
Purchases of marketable securities | ( | ( | |
Capital expenditures | ( | ( | |
Proceeds from sales of fixed assets | |||
Net cash (used in) provided by investing activities | ( | ||
Cash flows from financing activities: | |||
Net proceeds from issuance of common stock | |||
Tax payment for employee shares withheld | ( | ( | |
Repurchase of common stock | ( | ( | |
Payment of excise tax associated with repurchase of common stock | ( | ( | |
Net cash used in financing activities | ( | ( | |
Effect of exchange rate differences on cash and cash equivalents | ( | ||
Net change in cash, cash equivalents and restricted cash | ( | ||
Cash, cash equivalents and restricted cash, beginning of year | |||
Cash and cash equivalents, end of period | $ | $ | |
Three Months Ended September 30, 2026 | Nine Months Ended September 30, 2026 | ||||||||||||||
Desalination | Wastewater | Corporate and Other(1) | Total | Desalination | Wastewater | Corporate and Other(1) | Total | ||||||||
(In thousands) | |||||||||||||||
Geographical market | |||||||||||||||
Middle East | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Africa | |||||||||||||||
Other | |||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Channel | |||||||||||||||
Original equipment manufacturer | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Aftermarket | |||||||||||||||
Megaproject | |||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Three Months Ended September 30, 2025 | Nine Months Ended September 30, 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other(1) | Total | Desalination | Wastewater | Corporate and Other(1) | Total | ||||||||
(In thousands) | |||||||||||||||
Geographical market | |||||||||||||||
Middle East | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Africa | |||||||||||||||
Other | |||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Channel | |||||||||||||||
Original equipment manufacturer | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Aftermarket | |||||||||||||||
Megaproject | |||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
September 30, 2026 | December 31, 2025 | ||
(In thousands) | |||
Accounts receivable, net | $ | $ | |
Contract assets, current (included in prepaid expenses and other assets) | $ | $ | |
Contract liabilities: | |||
Contract liabilities, current | $ | $ | |
Total contract liabilities | $ | $ | |
September 30, 2026 | December 31, 2025 | ||
(In thousands) | |||
Contract liabilities, beginning of year | $ | $ | |
Revenue recognized | ( | ( | |
Cash received, excluding amounts recognized as revenue during the period | |||
Contract liabilities, end of period | $ | $ | |
Period | Remaining Performance Obligations | |
(In thousands) | ||
2026 (remaining three months) | $ | |
2027 | ||
2028 | ||
2029 | ||
Total | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
(In thousands, except per share amounts) | ||||||||
Numerator | ||||||||
Net income (loss) | $( | $ | $( | $( | ||||
Denominator (weighted average shares) | ||||||||
Basic common shares outstanding | ||||||||
Stock options | ||||||||
RSUs | ||||||||
Diluted common shares outstanding | ||||||||
Income (Loss) Per Share | ||||||||
Basic | $ ( | $ | $ ( | $ ( | ||||
Diluted | $ ( | $ | $ ( | $ ( | ||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
(In thousands) | |||||||
Anti-dilutive equity award shares | |||||||
September 30, 2026 | December 31, 2025 | ||
(In thousands) | |||
Raw materials | $ | $ | |
Work in process | |||
Finished goods | |||
Inventories, gross | |||
Valuation adjustments for excess and obsolete inventory | ( | ( | |
Inventories, net | $ | $ | |
September 30, 2026 | December 31, 2025 | ||
(In thousands) | |||
Accrued expenses and other liabilities, current | |||
Payroll, benefits, incentives and commissions payable | $ | $ | |
Warranty reserve | |||
Restructuring accrual | |||
Income taxes payable | |||
Other accrued expenses and other liabilities | |||
Total accrued expenses and other liabilities | |||
Other liabilities, non-current | |||
Total accrued expenses, and current and non-current other liabilities | $ | $ | |
Severance and Benefits | |
(In thousands) | |
Balance, as of December 31, 2024 | $ |
Restructuring provision, net of adjustments | |
Cash paid | ( |
Balance, as of December 31, 2025 | $ |
Restructuring provision | |
Cash paid | ( |
Balance, as of September 30, 2026 | $ |
September 30, 2026 | December 31, 2025 | ||||||||
Pricing Category | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||
(In thousands) | |||||||||
Cash equivalents | |||||||||
Money market securities | Level 1 | $ | $ | $ | $ | ||||
U.S. treasury securities | Level 2 | ||||||||
Total cash equivalents | |||||||||
Short-term investments | |||||||||
U.S. treasury securities | Level 2 | ||||||||
Corporate notes and bonds | Level 2 | ||||||||
Total short-term investments | |||||||||
Long-term investments | |||||||||
U.S. treasury securities | Level 2 | ||||||||
Corporate notes and bonds | Level 2 | ||||||||
Total long-term investments | |||||||||
Total short and long-term investments | |||||||||
Total | $ | $ | $ | $ | |||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
(In thousands, except percentages) | |||||||
Provision for (benefit from) income taxes | $( | $ | $( | $( | |||
Discrete items | ( | ( | ( | ||||
Provision for (benefit from) income taxes, excluding discrete items | $( | $ | $( | $( | |||
Effective tax rate | |||||||
Effective tax rate, excluding discrete items | |||||||
Three Months Ended September 30, 2026 | Nine Months Ended September 30, 2026 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
Revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Cost of revenue | |||||||||||||||
Restructuring - inventory reserve | |||||||||||||||
Gross profit (loss) | ( | ( | |||||||||||||
Operating expenses | |||||||||||||||
General and administrative | |||||||||||||||
Sales and marketing | |||||||||||||||
Research and development | |||||||||||||||
Restructuring charges | |||||||||||||||
Impairment of goodwill | |||||||||||||||
Total operating expenses | |||||||||||||||
Operating loss | $( | $( | $( | $( | $( | $( | $( | $( | |||||||
Three Months Ended September 30, 2025 | Nine Months Ended September 30, 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
Revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Cost of revenue | |||||||||||||||
Gross profit (loss) | ( | ( | |||||||||||||
Operating expenses | |||||||||||||||
General and administrative | |||||||||||||||
Sales and marketing | |||||||||||||||
Research and development | |||||||||||||||
Restructuring charges | |||||||||||||||
Total operating expenses | |||||||||||||||
Operating income (loss) | $ | $( | $( | $ | $ | $( | $( | $( | |||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2026 | 2025 | 2026 | 2025 | |||||
Product revenue by country:(1) | ||||||||
Morocco | ** | ** | ||||||
Egypt | ** | ** | ** | |||||
India | ** | ** | ||||||
Saudi Arabia | ** | |||||||
Spain | ** | ** | ** | |||||
China | ** | ** | ** | |||||
Others(2) | ||||||||
Total | ||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||
Segment | 2026 | 2025 | 2026 | 2025 | |||||
Customer A | Desalination | ** | ** | ||||||
Customer B | Desalination | ** | ** | ** | |||||
Customer C | Desalination | ** | ** | ** | |||||
Number of Shares Purchased | Average Price Paid per Share(1) | Plan Activity | |||||
(In millions) | |||||||
May 2026 Authorization | $ | ||||||
Repurchases under May 2026 Authorization | $ | ( | |||||
Remaining amount under May 2026 Authorization | $ |
Three Months Ended September 30, | |||||||||||
2026 | 2025 | ||||||||||
Revenue | % of Revenue | Revenue | % of Revenue | Change | |||||||
(In thousands, except percentages) | |||||||||||
Original equipment manufacturer | $6,222 | 56% | $8,962 | 28% | $(2,740) | (31%) | |||||
Aftermarket | 4,040 | 36% | 4,638 | 14% | (598) | (13%) | |||||
Megaproject | 934 | 8% | 18,400 | 58% | (17,466) | (95%) | |||||
Total revenue | $11,196 | 100% | $32,000 | 100% | $(20,804) | (65%) | |||||
Nine Months Ended September 30, | |||||||||||
2026 | 2025 | ||||||||||
Revenue | % of Revenue | Revenue | % of Revenue | Change | |||||||
(In thousands, except percentages) | |||||||||||
Original equipment manufacturer | $17,988 | 55% | $21,320 | 31% | $(3,332) | (16%) | |||||
Aftermarket | 10,906 | 33% | 13,558 | 20% | (2,652) | (20%) | |||||
Megaproject | 4,004 | 12% | 33,238 | 49% | (29,234) | (88%) | |||||
Total revenue | $32,898 | 100% | $68,116 | 100% | $(35,218) | (52%) | |||||
Three Months Ended September 30, | |||||||||||||||
2026 | 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
Middle East | $3,898 | $27 | $— | $3,925 | $6,194 | $168 | $— | $6,362 | |||||||
Africa | 326 | — | — | 326 | 10,323 | — | — | 10,323 | |||||||
Other | 6,469 | 449 | 27 | 6,945 | 12,593 | 2,650 | 72 | 15,315 | |||||||
Total revenue | $10,693 | $476 | $27 | $11,196 | $29,110 | $2,818 | $72 | $32,000 | |||||||
Nine Months Ended September 30, | |||||||||||||||
2026 | 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
Middle East | $12,486 | $27 | $77 | $12,590 | $16,483 | $168 | $93 | $16,744 | |||||||
Africa | 997 | — | — | 997 | 12,238 | — | — | 12,238 | |||||||
Other | 17,600 | 1,563 | 148 | 19,311 | 33,648 | 5,294 | 192 | 39,134 | |||||||
Total revenue | $31,083 | $1,590 | $225 | $32,898 | $62,369 | $5,462 | $285 | $68,116 | |||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2026 | 2025 | Change | 2026 | 2025 | Change | ||||||
(In thousands, except percentage and basis point) | |||||||||||
Gross profit | $4,197 | $20,558 | $(16,361) | $15,856 | $42,970 | $(27,114) | |||||
Gross margin | 37.5% | 64.2% | (2,670) bps | 48.2% | 63.1% | (1,490) bps | |||||
Three Months Ended September 30, | |||||||||||||||
2026 | 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
Operating expenses | |||||||||||||||
General and administrative | $1,621 | $208 | $4,883 | $6,712 | $719 | $699 | $6,096 | $7,514 | |||||||
Sales and marketing | 2,678 | 1,051 | 436 | 4,165 | 2,539 | 1,165 | 2,010 | 5,714 | |||||||
Research and development | 1,391 | 284 | 1,440 | 3,115 | 1,659 | 161 | 1,848 | 3,668 | |||||||
Total operating expenses | $5,690 | $1,543 | $6,759 | $13,992 | $4,917 | $2,025 | $9,954 | $16,896 | |||||||
Nine Months Ended September 30, | |||||||||||||||
2026 | 2025 | ||||||||||||||
Desalination | Wastewater | Corporate and Other | Total | Desalination | Wastewater | Corporate and Other | Total | ||||||||
(In thousands) | |||||||||||||||
General and administrative | $3,402 | $2,061 | $14,505 | $19,968 | $2,352 | $1,962 | $19,443 | $23,757 | |||||||
Sales and marketing | 7,616 | 3,423 | 2,581 | 13,620 | 6,830 | 3,299 | 5,851 | 15,980 | |||||||
Research and development | 5,398 | 682 | 2,673 | 8,753 | 3,878 | 724 | 5,518 | 10,120 | |||||||
Restructuring charges | 335 | 18 | 2,038 | 2,391 | 107 | 103 | 329 | 539 | |||||||
Impairment of goodwill | — | — | 1,662 | 1,662 | — | — | — | — | |||||||
Total operating expenses | $16,751 | $6,184 | $23,459 | $46,394 | $13,167 | $6,088 | $31,141 | $50,396 | |||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
(In thousands) | |||||||
Interest income | $683 | $847 | $2,088 | $2,860 | |||
Other non-operating income (expense), net | (87) | 45 | 143 | 25 | |||
Total other income, net | $596 | $892 | $2,231 | $2,885 | |||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2026 | 2025 | 2026 | 2025 | ||||
(In thousands, except percentages) | |||||||
(Benefit from) provision for income taxes | $(2,869) | $680 | $(6,528) | $(589) | |||
Discrete items | 241 | (117) | (76) | (87) | |||
(Benefit from) provision for income taxes, excluding discrete items | $(2,628) | $563 | $(6,604) | $(676) | |||
Effective tax rate | 31.2% | 14.9% | 23.1% | 13.0% | |||
Effective tax rate, excluding discrete items | 28.6% | 12.4% | 23.3% | 14.9% | |||
Nine Months Ended September 30, | |||||
2026 | 2025 | Change | |||
(In thousands) | |||||
Net cash provided by operating activities | $28,096 | $11,693 | $16,403 | ||
Net cash (used in) provided by investing activities | (9,831) | 37,012 | (46,843) | ||
Net cash used in financing activities | (23,839) | (31,417) | 7,578 | ||
Effect of exchange rate differences on cash and cash equivalents | (20) | 58 | (78) | ||
Net change in cash, cash equivalents and restricted cash | $(5,594) | $17,346 | $(22,940) | ||
Period | Total Number of Shares Purchased | Average Price Paid per Share(1) | Total Number of Shares Purchased as Part of Publicly Announced Program | Maximum Number of Shares or Approximate Dollar Value(1) That May Yet be Purchased Under the Program | ||||||
(In thousands) | ||||||||||
July 1 – July 31, 2026 | 164,400 | $8.65 | 164,400 | $22,241 | ||||||
August 1 – August 31, 2026 | 51,700 | $8.70 | 51,700 | $21,791 | ||||||
September 1 – September 30, 2026 | 71,600 | $6.94 | 71,600 | $21,295 |
Exhibit Number | Exhibit Description | |
31.1* | Certification of Principal Executive Officer, pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2* | Certification of Principal Financial Officer, pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1** | Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101 | Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, “Financial Information” of this Quarterly Report on Form 10-Q. | |
104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. | |
ENERGY RECOVERY, INC. | |||||
Date: | November 4, 2026 | By: | /s/ ALEXANDER J. BUEHLER | ||
Alexander J. Buehler | |||||
Interim President and Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
Date: | November 4, 2026 | By: | /s/ AIDAN RYAN | ||
Aidan Ryan | |||||
Interim Chief Financial Officer | |||||
(Principal Financial Officer) | |||||